TradingHolo

The whole market. One view. Market data from our own platform. Not investment advice. Prices in listing currency with AED alongside; market cap in USD. Live = streaming now; Delayed 15 min where the exchange requires it; At close = last official close.

News Calendar Economy IPOs ETFs Account

⌂Home ◈Markets ▦Screener 📈Tools ◎Portfolio

Skip to content

DFM General5,834.65−0.29%FTSE ADX9,829.37+0.47%TASI9,952.06−1.69%QE Index8,598.42−0.40%S&P 5007,718.05+0.36%Nasdaq 10029,563.24+0.11%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,151.64−0.49%DFM:EMIRATESNBDAED 31.58+0.25%ADX:IHCAED 356.60+1.31%SAU:2222SAR 25.48−1.24%DSMD:QNBKQAR 15.55−0.70%NAS:NVDA$216.59−0.23%NYSE:TSM$427.54+1.74%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.01+0.18%Gold$4,122.71−0.44%Brent$108.88−0.31%BTC$82,450.02+0.74%ETH$2,436.26+1.29%DFM General5,834.65−0.29%FTSE ADX9,829.37+0.47%TASI9,952.06−1.69%QE Index8,598.42−0.40%S&P 5007,718.05+0.36%Nasdaq 10029,563.24+0.11%Nifty 5022,888.95−1.11%Sensex73,852.90−1.17%KSE-100165,151.64−0.49%DFM:EMIRATESNBDAED 31.58+0.25%ADX:IHCAED 356.60+1.31%SAU:2222SAR 25.48−1.24%DSMD:QNBKQAR 15.55−0.70%NAS:NVDA$216.59−0.23%NYSE:TSM$427.54+1.74%NSE:RELIANCE₹1,202.00−0.76%KAR:OGDCRs 300.01+0.18%Gold$4,122.71−0.44%Brent$108.88−0.31%BTC$82,450.02+0.74%ETH$2,436.26+1.29%

Stock markets

🇦🇪UAEDFM · ADX · DFM GeneralClosed 🇸🇦Saudi ArabiaTadawul · TASIClosed 🇶🇦QatarQSE · QE GeneralClosed 🇺🇸United StatesNasdaq · NYSE · S&P 500Open 🇮🇳IndiaNSE · BSE · Nifty 50Closed 🇵🇰PakistanPSX · KSE-100Closed

Other assets

₿CryptoRanked by volume · 24/7 🥇Gold, FX & economyDubai gold, AED crosses, rates ◫ETFsIndex, sector and gold funds

Explore

▦Market mapEvery market as a heatmap 📅Calendar & IPOsEarnings, dividends, listings, releases ⌁Options flow · Ownership · PoliticsUS filings and tapes

⚲Stock screenerAll six markets, one row per company ★Ready-made screensStarting points with a point of view 📁My saved screensSaved rules with alerts on new matches ⇄CompareUp to five, side by side

📈ChartingDrawings, indicators, replay ▶Strategy MakerWrite a rule, test it on history ⇄CompareSide by side 🔔AlertsPrice, earnings, screens, strategies

⌕

Sign in Create account👤

Aquestive Therapeutics Inc · Overview · TradingHolo

Markets › United States › NAS › AQST

A

Aquestive Therapeutics Inc

NAS:AQSTHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$3.83+1.32%At closeAt close · Tue 20 Oct · ≈ AED 14.07 · Market cap $480.71M · Next earnings Wed 4 Nov · Extended $3.85 +0.52%

🔔 Alert▶ Test a strategy

Overview Chart Financials Valuation Forecasts Dividends Ownership Options Shorts News Profile

1D

+1.3%

1M

−18.9%

3M

−4.3%

6M

−12.5%

1Y

−48.5%

Why it's moving today

No company news in the last day; the move tracks its market and sector.

AQST +1.32% today

✦ This week in three lines

No written digest yet for AQST. The figures on this page are the source when one is written.

Financials

USD millions · annual5Y CAGR −0.6%

Valuation

P/E vs sector−5.7× vs −1.7×

Price / Book vs sector−14.1× vs 2.0×

Price / Sales vs sector10.7× vs 3.9×

Price / Free cash flow vs sector−9.0× vs −1.6×

Forecasts

9 buy0 hold0 sell9 analysts

Average target$0.0000 −100.0%

Analysts0

EPS surprises, last 82 beats

Dividends

Yield0.0%

Annual payout—

Payout ratio0.0%

Next ex-date—

Years of growth—

Latest news

All AQST news →

REAquestive Therapeutics Announces FDA Acceptance Of Anaphylm™ NDA Resubmission And PDUFA Goal Date Of March 16, 2027

Reuters · 5 d ago

TRAquestive Announces FDA Acceptance of Anaphylm NDA Resubmission, PDUFA Date Set for March 16, 2027

TradingView · 5 d ago

SEAquestive announces FDA review of Anaphylm sublingual film

Seeking Alpha · 5 d ago

Key facts

At close · Tue 20 Oct

Market cap (USD)$480.71M

P/E−5.7×

Dividend yield0.0%

52-week range$2.93 – $7.55

Avg volume (20d)2,225,829

Shares outstanding125,512,000

Beta1.43

Short interest26.2% of float

Next earningsWed 4 Nov

Radar Score

—

Value—

Quality—

Momentum—

Income—

Peer percentile within United States Healthcare0–100 · null when more than one input is missing

About

Aquestive Therapeutics, Inc. is a pharmaceutical company focused on discovering, developing, and commercializing products to address significant unmet medical needs across both the United States and international markets. The company's commercialized portfolio includes: Sympazan, an oral soluble film formulation of…

Sector

Healthcare

IndustryNormal

ExchangeNAS

Peers

LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE

—−1.33%

JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE

—−0.69%

ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE

—−0.96%

UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE

—+1.36%